Company intelligence / Profile preview

Sebia

Lisses, Île-de-France, Francesebia.com ↗

Ownership: Private
Employees: ~1001
Development stage: Other

Overview

Sebia is a global leader in clinical protein electrophoresis and capillary electrophoresis-based diagnostics. Its commercialized platforms are widely used for the diagnosis and monitoring of multiple myeloma, diabetes management via HbA1c assays, detection of hemoglobinopathies, autoimmune disorders, and other rare conditions. The company continues to innovate with new tests and automated equipment in its pipeline.

Therapeutic areas: HematologyEndocrinologyOncologyImmunology
Modalities: DeviceReagent
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Sebia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sebia.

Explore the full profile